BioInfoTeam · Sameta Biomedical
Senior PhDs engaged on project terms — bridging the gap when hiring cycles can't match your research velocity.
Single-cell, multi-omics, and regulatory-grade pipelines for pharma, biotech, academic groups, and CROs.
Senior lead · PI
Miroslav Chovanec
Cancer Research Institute · BMC SAS
Senior team
h-index 28
170+ publications · 50+ years combined
An outsourced senior bioinformatics team — custom scope, transparent process, no template pipelines.
The science is solvable. The constraint is people, infrastructure and calendar — and they all push against the same deadline.
And then you need a second one for backup. Plus HPC infrastructure, plus pipelines, plus documentation. Your project doesn't have that runway.
Standard pipelines only carry you so far. Modern omics needs senior judgment on QC, batch effects, integration, and statistical models.
Submission windows close. Funding rounds close. Peer reviewers don't accept 'we ran out of compute time' as an answer.
A wet-lab biologist needs to act on the result. A regulator needs to verify it. Most analysts can write for one audience, not both.
Storage, schedulers, secure data transfer, audit trails, reproducibility. You can buy that, or you can buy a team that already runs it.
We don't sell shrink-wrapped pipelines. Every engagement starts with a FREE scoping session, runs through a small pilot, and only after full agreement then moves to full delivery. You commit when you have evidence — not on a sales call.
Proven delivery
Market context
~14%
Estimated CAGR of the bioinformatics services market through 2030. Pharma and biotech are the fastest-growing end users; AI and multi-omics integration are pushing demand for senior expertise.
Source: Grand View Research / Precedence Research, public market reports.
Processed data delivered on the agreed timeline — reproducible, documented, defensible
Reports built for publication, regulatory submission, or internal go / no-go decisions
Reproducible Nextflow / Snakemake pipelines you keep after handover
No need to hire, onboard, or backfill an internal bioinformatics function
Flexible scaling — ramp up for a milestone, ramp down between phases
One scope, one delivery.
A defined deliverable — a study, a pipeline, a report. Scoped, priced, and delivered as a self-contained engagement.
Multi-phase programs.
For research programs that span quarters or years. We become a reliable bioinformatics partner across consecutive phases.
Senior bioinformatics, embedded.
A senior bioinformatician (or small team) operating as a direct extension of your internal R&D — your standups, your backlog.
A FREE scoping session: we define the question, methodology, effort, and timeline. You leave with a written plan — even if you don't continue with us.
A small first deliverable in 1–2 weeks. You see how we work, how we communicate, and how the output looks before you commit to the full project.
Full analysis, internally peer-reviewed by our senior team. Reports written for the audience that needs to act on them.
Documentation, reproducible pipelines, raw and processed outputs, and post-delivery support. You own everything.
A FREE scoping session: we define the question, methodology, effort, and timeline. You leave with a written plan — even if you don't continue with us.
A small first deliverable in 1–2 weeks. You see how we work, how we communicate, and how the output looks before you commit to the full project.
Full analysis, internally peer-reviewed by our senior team. Reports written for the audience that needs to act on them.
Documentation, reproducible pipelines, raw and processed outputs, and post-delivery support. You own everything.
vs. Big CROs
We are faster, more flexible, and senior-heavy from day one. You speak directly with the people running your analysis.
vs. Freelancers
We bring a team, internal peer review, methodology, GDPR-aligned processes, and signed NDAs — not a single point of failure.
vs. Hiring in-house
No multi-month search, no HPC build-out, no risk of mis-hire. You get senior output in weeks, not quarters.
10 — Risk reversal
There's no long-term commitment up front. If the pilot doesn't earn your trust, you stop. We'd rather lose the engagement at the pilot stage than mis-deliver the full project — and so would you.
Model 01
One scope, one delivery.
A defined deliverable — a study, a pipeline, a report. Scoped, priced, and delivered as a self-contained engagement.
Model 02
Multi-phase programs.
For research programs that span quarters or years. We become a reliable bioinformatics partner across consecutive phases.
Model 03
Senior bioinformatics, embedded.
A senior bioinformatician (or small team) operating as a direct extension of your internal R&D — your standups, your backlog.
Every project we run has a different scope: different data shape, different question, different downstream audience. A fixed price list would either over-charge small projects or quietly cap the quality of large ones. Custom pricing is the consequence of taking each project seriously.
Pricing is set after scoping — when both sides understand exactly what is being delivered. Our pipelines can handle 10, 100 or 10,000+ samples; the price reflects what the work actually is, not a marketing tier.
Get a written scope and a real estimateNextflow / Snakemake pipelines handed over with the project. You can re-run, audit, and extend them without us.
Methodology, parameters, versions, and chain-of-custody documented to a standard your QA team will recognize.
Every delivery is reviewed by a second senior team member before it reaches you. Built into the process, not optional.
Senior bioinformatics expertise, end to end. Three complementary specialists covering the full path from biological question to reproducible answer: DNA repair and genome stability, integrated multi-omics and host–pathogen biology, and the HPC pipeline engineering that makes every analysis re-runnable, auditable, and ready for peer review. Beyond this core expertise, additional senior team members are carefully selected based on the specific needs of each project.
50+
Years combined senior research experience
170+
Peer-reviewed publications
25–28
h-index range across leads
EU-funded
H2020 · ERA-NET · Marie-Curie · EFSA
Affiliations
Biomedical Research Centre SAS · University of Veterinary Medicine and Pharmacy in Košice · ICGEB · Sameta Biomedical
Lead · PIDirector — Cancer Research Institute, Biomedical Research Centre SAS
Experimental oncology · DNA repair · genome stability · biomarker discovery
Postdoctoral training at the Genome Damage & Stability Centre, University of Sussex. Awarded Personality of Science & Technology (2013). Leads translational research connecting DNA damage mechanisms to clinically actionable biomarkers.
PI · ICGEBHead — Laboratory of Biomedical Microbiology & Immunology · ICGEB Governor for Slovakia
Molecular proteomics · transcriptomic & proteomic analysis · neuroinvasion models · BSL-3 leadership
ERA Chair (FP7) and Marie-Curie IIF fellow. Principal investigator on H2020, ERA-NET and EFSA funded projects. Built Omnalysis, an in-house platform for integrated omics data analysis.
DevOpsVice-Dean for Science & Research — Faculty of Informatics and Information Technologies, Slovak University of Technology in Bratislava (FIIT STU)
Cancer genomics · explainable & generative AI · multi-omics integration · in silico medicine
Academic leader in bioinformatics, precision oncology and explainable AI. Former appointments at the University of Oxford, University of Basel and Roche Pharma Research and Early Diagnostics. Marie Skłodowska-Curie Fellow (2022); 14+ years of international research experience across the UK, Switzerland and Germany.
GDPR-aligned data handling, NDAs signed before specifics are exchanged, encrypted and access-controlled data transfers.
Transparent methods, versioned analyses, internal peer review, documentation written for audit and peer review.
HPC-grade compute, scalable storage, reproducible workflow engines (Nextflow / Snakemake), reliable handover packages.
Good fit
Not the right fit
We don't run countdown timers or fake "3 spots left" scarcity. The real urgency is in your calendar: grant submission deadlines, regulatory timelines, funding rounds, conference abstracts. Most of those are non-negotiable. Scoping starts the clock — the earlier we talk, the more options you have.
One short form. Output: a FREE scoping session within two weeks, a written methodology, and an honest opinion on whether we are the right team for the work.
Prefer a full page? Open the dedicated scoping form.
